China Life Sciences and Health Industry Client Briefing – September 2012 (October 4, 2012)

Explore:  China Life Sciences

In This Issue:

• Merck-Simcere Joint Venture Starts Business in Pudong (Shanghai Daily 2012-09-13) – September 14, 2012

• Pfizer Joint Venture Set to Hire 600 Staff (Bloomberg News 2012-09-14) – September 14, 2012

• Biotec IPO Approved (Agencies 2012-09-07) – September 7, 2012

• SFDA: ID Cards to be Shown When Purchasing Cold Medicines Containing Ephedrine (Caijing 2012-08-31) – September 3, 2012

• NDRC Adjusts Retail Price Caps of Some Medicines (China News Service 2012-09-19) – September 19, 2012

• Antitrust Investigation of Guangzhou Pharmaceutical Company Limited’s Merger with Guangzhou Baiyunshan Pharmaceutical Co., Ltd. Completed (Caixin Media 2012-09-20) – September 21, 2012

• Circular from the Medical Reform Office under the State Council Expected to Make M&As of Drug Distributors Easier in China (Economic Information Daily 2012-09-17) – September 17, 2012

• Alliance Boots Says to Buy $91 Million Stake in China Pharma Retailer (Reuters 2012-09-16) – September 17, 2012

• Dutch Health Store Chain Opens First China Shop (China Daily 2012-09-24) – September 25, 2012

• Health Care System to Get 400b Yuan Injection, including prevention and control of chronic disease (China Daily 2012-09-04) – September 3, 2012

• China to Strengthen Urban-Rural Medical Co-op (Xinhua News Agency 2012-09-25) – September 25, 2012

• China Encourages Private Investment in Hospitals: Minister (CNTV 2012-09-17) – September 18, 2012

• Beijing Policies Encourage Development of Private Hospitals (China Daily 2012-08-31) – September 3, 2012

• Court Case Reveals Medical Companies Using Gutter Oil (Shanghai Daily 2012-09-03) – September 3, 2012

Please see full Alert below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Written by:

Published In:

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Reed Smith | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »

All the intelligence you need, in one easy email:

Great! Your first step to building an email digest of JD Supra authors and topics. Log in with LinkedIn so we can start sending your digest...

Sign up for your custom alerts now, using LinkedIn ›

* With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name.